Literature DB >> 1569041

Detection of three distinct phospholipases A2 in cultured mast cells.

M Murakami1, I Kudo, M Umeda, A Matsuzawa, M Takeda, M Komada, Y Fujimori, K Takahashi, K Inoue.   

Abstract

Phospholipase A2 activity in lysates of mast cells such as rat mastocytoma RBL-2H3 cells and mouse bone marrow-derived IL-3-dependent mast cells (BMMC) was measured using phosphatidylcholine (PC), phosphatidylethanolamine (PE), or phosphatidylserine (PS) as a substrate. Both types of cells exhibited phospholipase A2 activity with a similar pH profile; the optimum pH observed with PS as a substrate was 5.5-7.4, whereas that with PE or PC was 8.0-9.0. PE and PC bearing an arachidonate at the sn-2 position were cleaved more efficiently by PE, PC-hydrolyzing phospholipase A2 than phospholipids with a linoleate. A monoclonal antibody raised against rabbit platelet 85-kDa cytosolic phospholipase A2 absorbed the PE, PC-hydrolyzing activity. PS-hydrolyzing activity was purified from RBL-2H3 cells and BMMC by sequential heparin-Sepharose, butyl-Toyo-pearl, and reverse-phase HPLC. On reverse-phase HPLC, the PS-hydrolyzing activity of RBL cells was separated into two peaks, A and B. The peak B activity was inhibited by the anti-rat 14-kDa group II phospholipase A2 antibody, while the peak A activity was not. The partially purified peak A activity hydrolyzed PS about 10-fold more efficiently than PE at optimum pH of 5.5-7.4. No appreciable hydrolysis was observed with PC or phosphatidylinositol (PI). Thus, mast cells may express at least three distinct phospholipases A2; 14-kDa group II phospholipase A2, 85-kDa cytosolic arachidonate preferential phospholipase A2, and a novel phospholipase A2 that shows high substrate specificity for PS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569041     DOI: 10.1093/oxfordjournals.jbchem.a123733

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

1.  Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors.

Authors:  Neerad C Mishra; Jules Rir-sima-ah; R Thomas Boyd; Shashi P Singh; Sravanthi Gundavarapu; Raymond J Langley; Seddigheh Razani-Boroujerdi; Mohan L Sopori
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

2.  High specificity of human secretory class II phospholipase A2 for phosphatidic acid.

Authors:  Y Snitko; E T Yoon; W Cho
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium.

Authors:  O S Jamal; P G Conaghan; A M Cunningham; P M Brooks; V F Munro; K F Scott
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

4.  Purification and characterization of a calcium-independent acidic phospholipase A2 from rat lung.

Authors:  R Wang; C R Dodia; M K Jain; A B Fisher
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

5.  Phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in MCII mast cells mediated by high-affinity Fc receptor for IgE.

Authors:  S Currie; E F Roberts; S M Spaethe; N W Roehm; R M Kramer
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

6.  Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate.

Authors:  D S Grass; R H Felkner; M Y Chiang; R E Wallace; T J Nevalainen; C F Bennett; M E Swanson
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

7.  Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides.

Authors:  C F Bennett; M Y Chiang; L Wilson-Lingardo; J R Wyatt
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

Review 8.  Mast cells: from lipid droplets to lipid mediators.

Authors:  Andrea Dichlberger; Petri T Kovanen; Wolfgang J Schneider
Journal:  Clin Sci (Lond)       Date:  2013-08       Impact factor: 6.124

9.  Group II phospholipase A(2) in human gingiva with periodontal disease.

Authors:  H Shinohara; T Komatsubara; H Tojo; M Okamoto; S Nishikawa; T Nagata; H Ishida
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

Review 10.  Biology of secretory phospholipase A2.

Authors:  Boris B Boyanovsky; Nancy R Webb
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-14       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.